Cargando…

The Effect of Sodium Channel Blocker, Mexiletine, on Body Weight in Type 2 Diabetes Patients with Visceral Obesity

OBJECTIVE: Mexiletine is an anti-arrhythmic agent also used for the treatment of painful diabetic neuropathy. In this study, the effect of mexiletine on body weight was evaluated in type 2 diabetes patients with diabetic neuropathy exhibiting visceral obesity. METHODS: Type 2 diabetes patients with...

Descripción completa

Detalles Bibliográficos
Autor principal:	Ueno, Naohiko
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	SAGE Publications 2019
Materias:	Original Article
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6343451/ https://www.ncbi.nlm.nih.gov/pubmed/30733634 http://dx.doi.org/10.1177/1179551418825049

Ejemplares similares

Molecular Modeling of Cardiac Sodium Channel with Mexiletine
por: Zhorov, Boris S.
Publicado: (2022)

Calixmexitil: Calixarene-based Cluster of Mexiletine with Amplified Anti-myotonic Activity as A Novel Use-dependent Sodium Channel Blocker
por: Delnavaz Shahr, Amirali, et al.
Publicado: (2019)

Dual Action of Mexiletine and Its Pyrroline Derivatives as Skeletal Muscle Sodium Channel Blockers and Anti-oxidant Compounds: Toward Novel Therapeutic Potential
por: De Bellis, Michela, et al.
Publicado: (2018)

Molecular Insights into the Local Anesthetic Receptor within Voltage-Gated Sodium Channels Using Hydroxylated Analogs of Mexiletine
por: Desaphy, Jean-François, et al.
Publicado: (2012)

Gating Properties of Mutant Sodium Channels and Responses to Sodium Current Inhibitors Predict Mexiletine-Sensitive Mutations of Long QT Syndrome 3
por: Li, Gang, et al.
Publicado: (2020)

A Case of Long QT Syndrome Type 3 Aggravated by Beta-Blockers and Alleviated by Mexiletine: The Role of Epinephrine Provocation Test
por: Park, Junbeom, et al.
Publicado: (2013)

A patient with mexiletine-related psychosis
por: Shailesh, Fnu, et al.
Publicado: (2011)

Synergistic Effect of Dofetilide and Mexiletine on Prevention of Atrial Fibrillation
por: Liu, Guizhi, et al.
Publicado: (2017)

Mexiletine as a treatment for primary erythromelalgia: normalization of biophysical properties of mutant L858F Na(V)1.7 sodium channels
por: Cregg, R, et al.
Publicado: (2014)

Experience with oral mexiletine in primary erythromelalgia in children
por: Iqbal, Javeed, et al.
Publicado: (2009)

Inhibition of hERG potassium channel by the antiarrhythmic agent mexiletine and its metabolite m-hydroxymexiletine
por: Gualdani, Roberta, et al.
Publicado: (2015)

Coronary microvascular function and visceral adiposity in patients with normal body weight and type 2 diabetes
por: Chowdhary, Amrit, et al.
Publicado: (2022)

Neuroprotective effects of blockers for T-type calcium channels
por: Wildburger, Norelle C, et al.
Publicado: (2009)

Docking Studies of Phthalimide Pharmacophore as a Sodium Channel Blocker
por: Iman, Maryam, et al.
Publicado: (2013)

PITX2 Modulates Atrial Membrane Potential and the Antiarrhythmic Effects of Sodium-Channel Blockers
por: Syeda, Fahima, et al.
Publicado: (2016)

Comparative effect of angiotensin II type I receptor blockers and calcium channel blockers on laboratory parameters in hypertensive patients with type 2 diabetes
por: Nishida, Yayoi, et al.
Publicado: (2012)

Mexiletine-like cellular electrophysiological effects of GS967 in canine ventricular myocardium
por: Hézső, Tamás, et al.
Publicado: (2021)

Mexiletine rescues a mixed biophysical phenotype of the cardiac sodium channel arising from the SCN5A mutation, N406K, found in LQT3 patients
por: Hu, Rou-Mu, et al.
Publicado: (2018)

New Insights into Cardiac and Brain Sodium Channels Modulation by Beta Blockers
por: Chahine, Mohamed
Publicado: (2011)

Prognostic Significance of the Sodium Channel Blocker Test in Patients With Brugada Syndrome
por: Ueoka, Akira, et al.
Publicado: (2018)

How to Boost Efficacy of a Sodium Channel Blocker: The Devil Is in the Details
por: Nowak, Madison B., et al.
Publicado: (2019)

Erratum to: Voltage-gated Sodium Channels and Blockers: An Overview and Where Will They Go?
por: Li, Zhi-mei, et al.
Publicado: (2021)

Management of ventricular tachycardia--role of mexiletine : proceedings of a symposium held in Copenhagen, Denmark, 25th-27th May, 1978 /
Publicado: (1978)

A Case of Mexiletine-induced Hypersensitivity Syndrome Presenting as Eosinophilic Pneumonia
por: Lee, Sang-Pyo, et al.
Publicado: (2010)

Therapeutic drug monitoring of mexiletine at a large academic medical center
por: Nei, Scott D, et al.
Publicado: (2016)

Case report: Mexiletine suppresses ventricular arrhythmias in Andersen-Tawil syndrome
por: Yang, Jing, et al.
Publicado: (2022)

Mexiletine in spinal and bulbar muscular atrophy: a randomized controlled trial
por: Yamada, Shinichiro, et al.
Publicado: (2022)

Effectiveness and safety of mexiletine in patients at risk for (recurrent) ventricular arrhythmias: a systematic review
por: van der Ree, Martijn H, et al.
Publicado: (2022)

Gene-Specific Therapy With Mexiletine Reduces Arrhythmic Events in Patients With Long QT Syndrome Type 3
por: Mazzanti, Andrea, et al.
Publicado: (2016)

Calcium Channel Blocker Enhances Beneficial Effects of an Angiotensin II AT(1) Receptor Blocker against Cerebrovascular-Renal Injury in type 2 Diabetic Mice
por: Rafiq, Kazi, et al.
Publicado: (2013)

Mexiletine Differentially Restores the Trafficking Defects Caused by Two Brugada Syndrome Mutations
por: Moreau, Adrien, et al.
Publicado: (2012)

Mexiletine Treatment for Neonatal LQT3 Syndrome: Case Report and Literature Review
por: Bagkaki, Alena, et al.
Publicado: (2021)

Mexiletine and False Positive Urine Drug Screen for Amphetamine: A Case Review
por: Sohal, Sumit, et al.
Publicado: (2021)

Designer Gelators for the Crystallization of a Salt Active Pharmaceutical Ingredient—Mexiletine Hydrochloride
por: Andrews, Jessica L., et al.
Publicado: (2022)

A comparative study on the effect of dopamine vs phenylephrine in improving the cutaneous analgesic effect of mexiletine in rats
por: Zheng, Kesong, et al.
Publicado: (2023)

Toward Overcoming Pyrethroid Resistance in Mosquito Control: The Role of Sodium Channel Blocker Insecticides
por: Niklas, Beata, et al.
Publicado: (2023)

Urate-Lowering Therapy Ameliorates Kidney Function in Type 2 Diabetes Patients With Hyperuricemia
por: Ueno, Naohiko
Publicado: (2017)

Tramadol as a Voltage-Gated Sodium Channel Blocker of Peripheral Sodium Channels Na(v)1.7 and Na(v)1.5
por: Bok, Chan-Su, et al.
Publicado: (2023)

Pleiotropic Effects of Calcium Channel Blockers
por: Preston Mason, R.
Publicado: (2012)

Effect of calcium channel blockers on incidence of diabetes: a meta-analysis
por: Noto, Hiroshi, et al.
Publicado: (2013)

Cannot write session to /tmp/vufind_sessions/sess_6uo4s8mdpqi9qcl8cq2361sdtv